Objectives Kenya is one of the first African countries to scale up a national HIV viral load
monitoring program. We sought to assess program scale up using the national database …

Background Access to routine virologic monitoring, critical to ensuring treatment success,
remains limited in low-and middle-income countries. We report on implementation of routine …

To achieve global targets for universal treatment set forth by the Joint United Nations
Programme on human immunode ficiency virus (HIV)/acquired immunodeficiency syndrome …

When antiretroviral therapy (ART) scale up began in Africa a decade ago, there was concern
that lack of laboratory monitoring for patients receiving antiretroviral drugs would be an …

Abstract The South African antiretroviral treatment guidelines recommend the use of human
immunodeficiency virus type 1 (HIV-1) load testing for patient monitoring and, in particular, to …

Introduction Routine viral load (VL) testing among persons living with Human
Immunodeficiency Virus (PLHIV) enables earlier detection of sub-optimal antiretroviral …

Background. The Joint United Nations Programme on HIV/AIDS (UNAIDS) third 90-90-90
target requires 90% of patients on antiretroviral treatment (ART) to be virally suppressed (< 1 …

Introduction The success of HIV treatment programmes globally has resulted in children with
perinatally acquired HIV reaching adolescence in large numbers. The number of …

Scaling up access to HIV viral load testing for individuals undergoing antiretroviral therapy in
low-resource settings is a global health priority, as emphasised by research showing the …

Abstract Background The Joint United Nations Programme on HIV/AIDS 90–90-90 goal
envisions 90% of all people receiving antiretroviral therapy to be virally suppressed by 2020 …